What is the recommended dose of cefalexin (Keflex) for cellulitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Recommended Dose of Keflex (Cephalexin) for Cellulitis

For adults with cellulitis, prescribe cephalexin 500 mg orally four times daily (every 6 hours) for 5 days, extending treatment only if the infection has not improved within this timeframe. 1, 2

Adult Dosing

The FDA-approved dosing for skin and soft tissue infections is 250 mg every 6 hours, but 500 mg every 6 hours is the standard dose used in clinical practice for cellulitis 2. The IDSA guidelines specifically list cephalexin 500 mg four times daily as the recommended oral agent for methicillin-susceptible staphylococcal skin infections 1.

Alternative Dosing Considerations

  • 500 mg every 12 hours may be used for mild, uncomplicated skin infections 2, though this is less commonly recommended for cellulitis specifically
  • High-dose regimen (1000 mg four times daily) showed fewer treatment failures (3.2% vs 12.9%) in a 2023 pilot trial, though with more minor adverse effects 3. This may be considered for more severe cases, but remains investigational

Pediatric Dosing

For children with cellulitis: 25-50 mg/kg/day divided into 4 doses (every 6 hours) 1, 2

  • For severe infections, this dose may be doubled
  • A recent 2025 study supports high-dose cefalexin 45 mg/kg (maximum 1.5 g) three times daily as effective and well-tolerated 4, though this was specifically for bone/joint infections

Treatment Duration

5 days is the recommended duration, but extend treatment if the infection has not improved within this period 1. The IDSA guidelines emphasize this 5-day minimum with extension as needed based on clinical response.

Key Clinical Considerations

When Cephalexin is Appropriate

Cephalexin targets streptococci and methicillin-susceptible Staphylococcus aureus (MSSA), which are the typical pathogens in non-purulent cellulitis 1. Use cephalexin for:

  • Mild cellulitis without systemic signs (no fever, tachycardia, or SIRS criteria)
  • No purulent drainage or abscess
  • No risk factors for MRSA

When to Choose Alternative Antibiotics

Do NOT use cephalexin alone if the patient has 1:

  • Penetrating trauma
  • Evidence of MRSA infection elsewhere or nasal colonization
  • Injection drug use
  • Purulent drainage
  • Systemic signs of infection (SIRS criteria: fever, tachycardia, tachypnea)

In these cases, add MRSA coverage with trimethoprim-sulfamethoxazole, doxycycline, or clindamycin, or switch to vancomycin for severe infections 1.

Evidence Quality Note

A 2017 randomized trial of 496 patients found that adding trimethoprim-sulfamethoxazole to cephalexin did NOT improve cure rates in the per-protocol analysis (83.5% vs 85.5%, p=0.50) 5. This supports using cephalexin alone for typical non-purulent cellulitis, though the modified intention-to-treat analysis showed some imprecision.

Common Pitfalls

  • Don't underdose: The 250 mg four times daily dose is insufficient for most cellulitis cases; use 500 mg four times daily
  • Don't forget to examine toe webs: Treating interdigital tinea pedis reduces recurrence risk 1
  • Don't overlook abscess: Always perform ultrasound if there's any concern for underlying abscess, as this requires drainage, not just antibiotics 1
  • Monitor for treatment failure: If no improvement by day 3-4, reassess for abscess, resistant organisms, or alternative diagnoses 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.